Roche has selected two health technology companies to deploy a wireless wearable system in a clinical trial on a drug for infants with spinal muscular atrophy.
The study will use BioRadio, a wireless wearable data acquisition system from Great Lakes NeuroTechnologies that records respiratory and pulmonary data from infants in near real time. Vivonoetics’ VivoSense software works in collaboration...
Great Lakes NeuroTechnologies, which makes mobile software and wearable devices for monitoring symptoms of Parkinson's disease, has released a new clinical version of its technology that supports continuous monitoring. Kinesia 360 is still a clinician-facing tool; it doesn't appear to be the direct-to-consumer offering the company promised last April when it received a $1.5 million NIH grant.
"...
Great Lakes NeuroTechnologies, a company using tablets and wearable sensors for Parkinson's diagnosis and therapy, will use a recent $1.5 million NIH grant to start a move toward direct-to-consumer marketability. This is the latest in a long series of NIH grants for the company since 2005 and brings the company's total grants to $14.2 million.
The system, called Kinesia HomeView, is currently...
It's one thing to detect the telltale stiffness, tremors, spasms and loss of muscle control of Parkinson's disease with wireless sensors, as Great Lakes Neurotechnologies is doing with its Kinesia HomeView system. It's another to add automatic medication administration to this type of technology.
A multi-country project funded by the European Union aims to do just that. Researchers in Spain,...
Parkinson's disease is considered a movement disorder, so it lends itself quite well to mobile technologies. At least one tablet-based device to measure Parkinsonian tremors is already on the market, while an iPhone measurement system passed muster in a clinical trial more than a year ago.
Two weeks ago at the AdvaMed 2011 medical technology conference in Washington, D.C., Great Lakes...
